clinical trial imaging market forecast, clinical trial imaging market trends, clinical trial imaging market size, clinical trial imaging market share, clinical trial imaging market,Global clinical trial imaging market
What is the present valuation and projected CAGR of the clinical trial imaging market?
The clinical trial imaging market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased sales and the distribution of clinical imaging software and services, increased risks of breast cancer, increased healthcare spending, rise in healthcare expenditure results in improved infrastructure, increased research and development spending by the pharmaceutical and biotechnological companies.
The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing chronic diseases, rising research and development expenditures, an increasing geriatric population, a growing number of clinical studies, and an increasing number of contract research organizations. Major trends in the forecast period include technological advancements enhancing imaging modalities, strategic initiatives by market players to expand capabilities and offerings, adoption of imaging-based approaches in drug development, advancements in molecular imaging and AI-driven analysis, and product innovation.
Get Your Free Sample of The Global Clinical Trial Imaging Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15765&type=smp
What key drivers have fueled the clinical trial imaging market’s development over the years?
The increasing prevalence of chronic diseases is expected to propel the growth of the clinical trial imaging market going forward. Chronic disease is a long-lasting condition that typically requires ongoing medical attention and can limit daily activities or quality of life. The increasing prevalence of chronic diseases is due to exposure to air pollution, chemicals, and toxins, lifestyle changes, and genetic factors. Clinical trial imaging provides efficient monitoring through imaging that can help patients understand their condition and the impact of treatments, improving adherence and satisfaction. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it is projected that by the year 2050, the number of individuals aged 50 years and above who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million.. Therefore, the increasing prevalence of chronic diseases drives the clinical trial imaging market.
What is the segmentation for the clinical trial imaging market?
The clinical trial imaging market covered in this report is segmented –
1) By Product And Services: Services, Software
2) By Modality: Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Other Modalities
3) By Application: Oncology, Neurology, Cardiology, Endocrinology, Dermatology, Hematology, Other Applications
4) By Distributer: Direct Sales, Tender Sales
5) By End User: Contract Research Organizations, Pharmaceutical And Biotechnology Companies, Medical Device Manufacturers, Academic And Government Research Institutes, Other End-Users
Subsegments:
1) By Services: Imaging Services For Diagnostics, Image Acquisition Services, Image Analysis Services, Image Management And Archiving Services
2) By Software: Imaging Software For Analysis, Image Processing Software, Radiology Information Systems (RIS), Picture Archiving And Communication Systems (PACS)
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/clinical-trial-imaging-global-market-report
Who are the most influential companies in the clinical trial imaging market?
Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL
What are the top industry trends projected to impact the clinical trial imaging market?
Major companies operating in the clinical trial imaging market are developing cloud-based image tools to provide better solutions and improve the efficiency of clinical trials. Cloud-based imaging tools are software applications and platforms that utilize cloud computing technology to store, manage, and analyze medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, launched a cutting-edge cloud-based image viewer tool. This innovative tool offers real-time, on-demand viewing and manipulation of high-resolution images, providing read-quality access to images in near real-time while eliminating manual steps that were previously required. It streamlines the image viewing process, eliminating manual steps and making image accessibility easy, secure and data privacy compliant. The tool offers full-resolution viewing and manipulation capabilities, empowering end users to gain valuable insights into their trial subject.
What are the major regional insights for the clinical trial imaging market, and which region holds the top position?
North America was the largest region in the clinical trial imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Clinical Trial Imaging Market Report 2025 Offer?
The clinical trial imaging market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Clinical trial imaging refers to the use of medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography scan (CT) scans, and X-rays, to capture detailed internal images of participants during clinical trials. These images help monitor disease progression, assess treatment efficacy, and ensure patient safety. It is a crucial component in evaluating the biological impact of new therapies and interventions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15765
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
